Abstract
Galectin-3 is a chimeric galectin involved in diverse intracellular and extracellular functions. Galectin-3 is synthesized in the cytoplasm and then released extracellularly by a poorly understood non-canonical secretion mechanism. As a result, it can play important roles both inside and outside the cell. One important extracellular role of galectin-3 is in modulating clathrin-independent endocytosis (CIE), a form of cellular internalization that is still not well understood. CIE, unlike clathrin-mediated endocytosis, has neither defined signaling sequences nor cytoplasmic machinery. As a result, extracellular interactions like the galectin-glycan interactions are thought to directly drive changes in CIE. This chapter discusses the methods designed to study the role of galectin-glycan interactions in CIE, which have provided us with insight into the functions of galectin-3 and cell surface glycans during CIE cargo internalization. These methods include media supplementation for metabolic glycoengineering, antibody internalization assays, lectin panels to assay changes in glycan patterns, exogenous galectin-3 supplementation, galectin-3 secretion assays, and in vitro assays to monitor the effect of galectins on CIE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Johannes L, Jacob R, Leffler H (2018) Galectins at a glance. J Cell Sci 131(9). https://doi.org/10.1242/jcs.208884
Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F (2002) Introduction to galectins. Glycoconj J 19(7):433–440. https://doi.org/10.1023/B:GLYC.0000014072.34840.04
Liu F-T, Patterson RJ, Wang JL (2002) Intracellular functions of galectins. Biochim Biophys Acta 1572(2):263–273. https://doi.org/10.1016/S0304-4165(02)00313-6
Ochieng J, Furtak V, Lukyanov P (2002) Extracellular functions of galectin-3. Glycoconj J 19(7):527–535. https://doi.org/10.1023/B:GLYC.0000014082.99675.2f
Nabi IR, Shankar J, Dennis JW (2015) The galectin lattice at a glance. J Cell Sci 128(13):2213–2219. https://doi.org/10.1242/jcs.151159
Anand IS, Rector TS, Kuskowski M, Adourian A, Muntendam P, Cohn JN (2013) Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. Eur J Heart Fail 15(5):511–518. https://doi.org/10.1093/eurjhf/hfs205
Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A (1998) Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin 3. Gastroenterology 115(2):287–296. https://doi.org/10.1016/S0016-5085(98)70195-7
Furtak V, Hatcher F, Ochieng J (2001) Galectin-3 mediates the endocytosis of β-1 integrins by breast carcinoma cells. Biochem Biophys Res Commun 289(4):845–850. https://doi.org/10.1006/bbrc.2001.6064
Iacobini C, Blasetti Fantauzzi C, Bedini R, Pecci R, Bartolazzi A, Amadio B, Pesce C, Pugliese G, Menini S (2018) Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice. Metabolism 83:149–158. https://doi.org/10.1016/j.metabol.2018.02.001
Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S (2000) Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 6(4):1389–1393
Kajitani K, Yanagimoto K, Nakabeppu Y (2017) Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation. Psychopharmacology 234(19):2919–2927
Kim H-J, Do I-G, Jeon H-K, Cho YJ, Park YA, Choi J-J, Sung CO, Lee Y-Y, Choi CH, Kim T-J, Kim B-G, Lee J-W, Bae D-S (2013) Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer. Hum Pathol 44(1):62–68. https://doi.org/10.1016/j.humpath.2012.04.010
Melin EO, Dereke J, Thunander M, Hillman M (2018) Depression in type 1 diabetes was associated with high levels of circulating galectin-3. Endocr Connect 7(6):819. https://doi.org/10.1530/ec-18-0108
O’Seaghdha CM, Hwang S-J, Ho JE, Vasan RS, Levy D, Fox CS (2013) Elevated galectin-3 precedes the development of CKD. J Am Soc Nephrol 24(9):1470–1477. https://doi.org/10.1681/ASN.2012090909
Pasquini LA, Millet V, Hoyos HC, Giannoni JP, Croci DO, Marder M, Liu FT, Rabinovich GA, Pasquini JM (2011) Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function. Cell Death Differ 18(11):1746–1756. https://doi.org/10.1038/cdd.2011.40
Piper SE, de Courcey J, Sherwood RA, Amin-Youssef GF, McDonagh TA (2016) Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: a pilot study. Int J Cardiol 207:279–281. https://doi.org/10.1016/j.ijcard.2016.01.179
Takemoto Y, Ramirez RJ, Yokokawa M, Kaur K, Ponce-Balbuena D, Sinno MC, Willis BC, Ghanbari H, Ennis SR, Guerrero-Serna G, Henzi BC, Latchamsetty R, Ramos-Mondragon R, Musa H, Martins RP, Pandit SV, Noujaim SF, Crawford T, Jongnarangsin K, Pelosi F, Bogun F, Chugh A, Berenfeld O, Morady F, Oral H, Jalife J (2016) Galectin-3 regulates atrial fibrillation remodeling and predicts catheter ablation outcomes. JACC Basic Transl Sci 1(3):143–154. https://doi.org/10.1016/j.jacbts.2016.03.003
Takenaka Y, Fukumori T, Raz A (2002) Galectin-3 and metastasis. Glycoconj J 19(7):543–549. https://doi.org/10.1023/B:GLYC.0000014084.01324.15
Thurston TLM, Wandel MP, von Muhlinen N, Foeglein Á, Randow F (2012) Galectin-8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482(7385):414–418. https://doi.org/10.1038/nature10744
Mayor S, Pagano RE (2007) Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8(8):603–612. http://www.nature.com/nrm/journal/v8/n8/suppinfo/nrm2216_S1.html
McMahon HT, Boucrot E (2011) Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 12(8):517–533. http://www.nature.com/nrm/journal/v12/n8/suppinfo/nrm3151_S1.html
Howes MT, Mayor S, Parton RG (2010) Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis. Curr Opin Cell Biol 22(4):519–527. https://doi.org/10.1016/j.ceb.2010.04.001
Mayor S, Parton RG, Donaldson JG (2014) Clathrin-independent pathways of endocytosis. Cold Spring Harb Perspect Biol 6(6):a016758. https://doi.org/10.1101/cshperspect.a016758
Sandvig K, Kavaliauskiene S, Skotland T (2018) Clathrin-independent endocytosis: an increasing degree of complexity. Histochem Cell Biol 150(2):107–118. https://doi.org/10.1007/s00418-018-1678-5
Johannes L, Parton RG, Bassereau P, Mayor S (2015) Building endocytic pits without clathrin. Nat Rev Mol Cell Biol 16(5):311–321. https://doi.org/10.1038/nrm3968. http://www.nature.com/nrm/journal/v16/n5/abs/nrm3968.html#supplementary-information
Lakshminarayan R, Wunder C, Becken U, Howes MT, Benzing C, Arumugam S, Sales S, Ariotti N, Chambon V, Lamaze C (2014) Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers. Nat Cell Biol 16(6):595
Mathew MP, Tan E, Saeui CT, Bovonratwet P, Liu L, Bhattacharya R, Yarema KJ (2015) Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib. Bioorg Med Chem Lett 25(6):1223–1227. https://doi.org/10.1016/j.bmcl.2015.01.060
Mathew MP, Tan E, Saeui CT, Bovonratwet P, Sklar S, Bhattacharya R, Yarema KJ (2016) Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells. Oncotarget 7(41):66491–66511. https://doi.org/10.18632/oncotarget.11582
Lajoie P, Partridge EA, Guay G, Goetz JG, Pawling J, Lagana A, Joshi B, Dennis JW, Nabi IR (2007) Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol 179(2):341–356. https://doi.org/10.1083/jcb.200611106
Mathew MP, Donaldson JG (2018) Distinct cargo-specific response landscapes underpin the complex and nuanced role of galectin-glycan interactions in clathrin-independent endocytosis. J Biol Chem 293(19):7222–7237. https://doi.org/10.1074/jbc.RA118.001802
Mathew MP, Donaldson JG (2019) Glycosylation and glycan interactions can serve as extracellular machinery facilitating clathrin-independent endocytosis. Traffic 20(4):295–300. https://doi.org/10.1111/tra.12636
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mathew, M.P., Donaldson, J.G., Hanover, J.A. (2022). Evaluating the Role of Galectins in Clathrin-Independent Endocytosis. In: Stowell, S.R., Arthur, C.M., Cummings, R.D. (eds) Galectins. Methods in Molecular Biology, vol 2442. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2055-7_21
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2055-7_21
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2054-0
Online ISBN: 978-1-0716-2055-7
eBook Packages: Springer Protocols